PEN

Penumbra Stock Price

289.78
3.57 (1.25%)
Upgrade to Real-Time
Afterhours (Closed)
289.78

Low
163.48

52 Week Range

High
320.00

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Penumbra Inc PEN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
3.57 1.25% 289.78 20:00:00
Open Price Low Price High Price Close Price Prev Close
286.47 285.23 290.00 289.78 286.21
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,738 119,909 $ 287.20 $ 34,438,320 309,482 163.48 - 320.00
Last Trade Time Type Quantity Stock Price Currency
19:00:00 12,659 $ 289.78 USD

Penumbra Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.57B 36.48M 28.98M $ 560.41M $ -8.80M -0.44 -1,773.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 563.00 6.70%

more financials information »

Penumbra News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week269.64290.00262.96279.45203,01020.147.47%
1 Month242.45290.00232.295253.66322,61947.3319.52%
3 Months279.82320.00232.295267.02272,1489.963.56%
6 Months197.24320.00163.49240.43445,71892.5446.92%
1 Year168.00320.00163.48227.62451,247121.7872.49%
3 Years165.60320.00107.50179.09405,730124.1874.99%
5 Years60.03320.0054.96156.11327,458229.75382.73%

Penumbra Description

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.


Your Recent History
NYSE
PEN
Penumbra
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.